Hepatic Complications of Cystic Fibrosis
Overview
Affiliations
74 patients with cystic fibrosis aged 1-19 years were assessed prospectively for 1-7 years for evidence of liver involvement. 20 of these patients were referred primarily because of hepatic problems. 3 of 4 with neonatal hepatitis recovered. Chronic active hepatitis developed in a further child but resolved spontaneously. 6 patients had abnormal liver-function tests without clinical evidence of liver disease. In 18 cirrhosis was detected at age 4-13 years. Liver disease was stable in these except terminally in 3 with cor pulmonale. The principal hepatic problem was variceal bleeding, which occurred in 6 patients. 50% of bleeds followed aspirin ingestion. This drug therefore should be avoided in such patients. 13 had hypersplenism. 2 had severe splenic pain necessitating splenectomy with lienorenal shunt, which was performed also in 2 patients who had bled. 3 remain well up to 5 years later. In 3 patients seen in the past 3 years injection sclerotherapy has controlled bleeding. This technique was well tolerated without the pain associated with, or intensive physiotherapy necessary after, shunt surgery; and this may be the method of choice for controlling variceal bleeding in cystic fibrosis.
Hypersplenism is related to age of onset of liver disease.
McCormick P, Walker S, Benepal R Ir J Med Sci. 2007; 176(4):293-6.
PMID: 17943410 DOI: 10.1007/s11845-007-0089-8.
Retrospective review of cystic fibrosis presenting as infantile liver disease.
Shapira R, Hadzic N, Francavilla R, Koukulis G, Price J, Mieli-Vergani G Arch Dis Child. 1999; 81(2):125-8.
PMID: 10490518 PMC: 1718019. DOI: 10.1136/adc.81.2.125.
Neonatal cholestasis as the presenting feature in cystic fibrosis.
Lykavieris P, Bernard O, Hadchouel M Arch Dis Child. 1996; 75(1):67-70.
PMID: 8813874 PMC: 1511658. DOI: 10.1136/adc.75.1.67.
Hepatobiliary sonography in cystic fibrosis.
Quillin S, Siegel M, Rothbaum R Pediatr Radiol. 1993; 23(7):533-5.
PMID: 8309756 DOI: 10.1007/BF02012141.
Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up.
FEIGELSON J, Anagnostopoulos C, Poquet M, Pecau Y, Munck A, Navarro J Arch Dis Child. 1993; 68(5):653-7.
PMID: 8280210 PMC: 1029335. DOI: 10.1136/adc.68.5.653.